Fredun Pharmaceuticals Balance Sheet Annual

Trade

BSE: 539730 | NSE: - | ISIN: INE194R01017 | Sector: Biotechnology & Drugs

708.00 +34.30 (5.09%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.28	3.44	2.07	1.13
Cash Equivalents	1.07	-	-	-
Short Term Investments	4.20	12.81	0.82	0.85
Cashand Short Term Investments	5.56	16.25	2.89	1.98
Accounts Receivable- Trade Net	64.85	34.56	90.27	41.08
Total Receivables Net	65.09	34.71	90.38	41.82
Total Inventory	175.00	150.12	46.46	67.57
Other Current Assets Total	11.55	15.13	12.92	18.71
Total Current Assets	257.20	216.21	152.65	130.08
Property/ Plant/ Equipment Total- Net	46.15	38.63	32.34	30.35
Intangibles Net	0.42	0.31	-	-
Long Term Investments	1.96	0.00	0.00	0.69
Other Long Term Assets Total	1.86	0.51	0.75	-
Total Assets	307.60	257.28	186.99	161.62
Accounts Payable	62.95	59.34	48.62	59.96
Notes Payable/ Short Term Debt	100.36	37.60	10.73	10.53
Other Currentliabilities Total	11.17	7.16	12.62	14.18
Total Current Liabilities	174.47	106.17	73.75	86.46
Long Term Debt	5.15	48.93	42.04	29.11
Total Long Term Debt	5.15	48.93	42.04	29.11
Total Debt	105.51	86.53	52.76	39.64
Deferred Income Tax	4.14	3.84	1.43	1.38
Other Liabilities Total	2.37	1.96	1.71	1.60
Total Liabilities	186.13	160.90	118.93	118.55
Common Stock Total	4.70	59.50	49.84	31.14
Retained Earnings( Accumulated Deficit)	116.77	36.87	18.22	11.93
Total Equity	121.47	96.38	68.06	43.07
Total Liabilities Shareholders' Equity	307.60	257.28	186.99	161.62
Total Common Shares Outstanding	0.47	0.45	0.44	0.40
Tangible Book Valueper Share Common Eq	257.60	211.96	153.54	107.96
Property/ Plant/ Equipment Total- Gross	-	51.03	42.14	37.99
Accumulated Depreciation Total	-	-12.40	-9.80	-7.64
Note Receivable- Long Term	-	1.62	1.25	0.50
Accrued Expenses	-	2.07	1.79	1.78
Current Portof LT Debt/ Capital Leases	-	0.00	-	-
Other Equity Total	-	0.00	-	-